BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. – Neurocrine Biosciences, Inc. Transaction History
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. portfolio value:
$56.66M
portfolio value
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +19.13% | 85.68K shares | 13.01M | $106.21 | 533.50K |
| Q2 2022 | share | Increase | +24.75% | 88.84K shares | 9.99M | $97.48 | 447.81K |
| Q1 2022 | share | Decrease | -3.65% | -13.61K shares | 1.92M | $93.75 | 358.97K |
| Q4 2021 | share | Decrease | -4.89% | -19.15K shares | -5.83M | $84.63 | 372.59K |
| Q3 2021 | share | Decrease | -0.30% | -1.19K shares | -668K | $95.91 | 391.75K |
| Q2 2021 | share | Increase | +21.48% | 69.48K shares | 6.78M | $97.32 | 392.94K |
| Q1 2021 | share | Increase | +25.36% | 65.43K shares | 6.72M | $97.25 | 323.46K |
| Q4 2020 | share | Decrease | -2.22% | -5.86K shares | -644K | $95.85 | 258.02K |
| Q3 2020 | share | Increase | +19.22% | 42.54K shares | -1.62M | $96.16 | 263.89K |
| Q2 2020 | share | Decrease | -6.16% | -14.53K shares | 6.58M | $122 | 221.35K |
| Q1 2020 | share | Increase | +16.26% | 32.99K shares | -1.39M | $86.55 | 235.88K |
| Q4 2019 | share | Decrease | -31.93% | -95.18K shares | -5.05M | $107.49 | 202.89K |
| Q3 2019 | share | Decrease | -26.37% | -106.73K shares | -7.31M | $90.11 | 298.07K |
| Q2 2019 | share | Increase | +10.34% | 37.93K shares | 1.85M | $84.43 | 404.81K |
| Q1 2019 | share | Increase | +103.00% | 186.15K shares | 19.95M | $88.1 | 366.87K |
| Q4 2018 | share | Decrease | -6.09% | -11.72K shares | -11.29M | $71.41 | 180.72K |
| Q3 2018 | share | Decrease | -21.81% | -53.69K shares | -519K | $122.95 | 192.45K |
| Q2 2018 | share | Increase | +124.29% | 136.40K shares | 15.08M | $98.24 | 246.14K |
| Q1 2018 | share | Decrease | -56.31% | -141.45K shares | -10.39M | $82.93 | 109.74K |
| Q4 2017 | share | Decrease | -51.95% | -271.60K shares | -12.54M | $77.59 | 251.19K |
| Q3 2017 | share | Increase | +34.18% | 133.17K shares | 14.11M | $61.28 | 522.80K |
| Q2 2017 | share | Increase | +86.26% | 180.43K shares | 8.86M | $46 | 389.62K |
| Q1 2017 | share | Increase | +12.83% | 23.78K shares | 1.88M | $43.3 | 209.18K |
| Q4 2016 | share | Increase | +8.56% | 14.61K shares | -1.47M | $38.7 | 185.40K |
| Q3 2016 | share | Decrease | -6.80% | -12.47K shares | 320K | $50.64 | 170.79K |
| Q2 2016 | share | Increase | +209.35% | 124.02K shares | 5.98M | $45.45 | 183.26K |
| Q1 2016 | share | Increase | 0.00% | 59.24K shares | 2.34M | $39.55 | 59.24K |